Haleon plc Files Form 6-K on Share Transaction
Ticker: HLNCF · Form: 6-K · Filed: Aug 5, 2025 · CIK: 1900304
Sentiment: neutral
Topics: share-transaction, disclosure, foreign-private-issuer
TL;DR
Haleon bought back its own stock on Aug 5, 2025. Details light.
AI Summary
Haleon plc announced on August 5, 2025, that it has completed a transaction involving its own shares. The filing, a Form 6-K, details this transaction as required for foreign private issuers. Specific details regarding the nature or financial impact of the share transaction were not provided in this summary document.
Why It Matters
This filing indicates corporate activity related to Haleon's own stock, which could signal management's view on the company's valuation or be part of a broader capital allocation strategy.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of a share transaction and does not contain information that inherently increases risk.
Key Players & Entities
- Haleon plc (company) — Registrant
- 05 August 2025 (date) — Date of transaction announcement
- 001-41411 (other) — Commission File Number
FAQ
What specific transaction in own shares did Haleon plc undertake?
The filing states 'Transaction in Own Shares' as Exhibit 99.1, dated 05 August 2025, but does not provide specific details within the provided text.
What is the purpose of this Form 6-K filing?
This Form 6-K is a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, filed for the month of August 2025.
When was Haleon plc formerly known as?
Haleon plc was formerly known as DRVW 2022 Ltd, with a date of name change on 20211217.
What is Haleon plc's fiscal year end?
Haleon plc's fiscal year ends on December 31 (1231).
Where is Haleon plc's principal executive office located?
Haleon plc's principal executive offices are located at Building 5, First Floor, The Heights, Weybridge, Surrey, KT13 0NY.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on August 5, 2025 regarding Haleon plc (HLNCF).